Correction: The performance of a lateral flow SARS-CoV-2 antibody assay and semi-autonomous SARS-CoV-2 antisense and sense RNA fluorescence in situ hybridization assay in a prospective cohort pilot study within a Dutch military population
Inge D. Wijnberg, Anton J. Soons, Johan G. Reimerink, Marit Wiersma, Marie Christine J. Plat, Tom van Gool, Gijsbert J. Jansen, Cornelis Stijnis, Jack G. Koning, Adam Meijer
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing · Respiratory viral infections research
The affiliation for the third author is incorrect. Johan G. Reimerink is not affiliated with #3 but with #9: National Institute for Public Health and the Environment (RIVM), Centre for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, Bilthoven, NLD
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Wijnberg ID, Soons AJ, Reimerink JG, Wiersma M, Plat MCJ, van Gool T, et al. The performance of a lateral flow SARS-Co V-2 antibody assay and semi-autonomous SARS-Co V-2 antisense and sense RNA fluorescence in situ hybridization assay in a prospective cohort pilot study within a Dutch military population. P Lo S One. 2024;19(12):e 0309091. doi: 10.1371/journal.pone.0309091 39739954 PMC 11687928 · doi ↗ · pubmed ↗